Atlas Trials

Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer

Clinical trial NCT04494958 · COMPLETED

Trial details

NCT number
NCT04494958
Sponsor
Fundacion Oncosur
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Triple Negative Breast Cancer
Start date
2020-11-18
Primary completion
2023-12-14
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.